This page describes only the pharmacokinetics of a missed dose, not what to do about one — that is for the product label and a clinician.
Tirzepatide's ~5-day half-life is slightly shorter than semaglutide's, so levels decline a touch faster after a miss.
The normal 7-day interval already sits past one half-life, so the weekly trough is naturally lower than semaglutide's.
About half of the last dose remains at 5 days and about a quarter at 10 days.
Steady-state accumulation adds a buffer on top of any single dose.
Tirzepatide's ~5-day half-life1 is slightly shorter than semaglutide's, so levels decline a bit faster after a missed weekly dose — but still gradually, not abruptly. As always, what to *do* about a missed dose is for the product label and a clinician; here is only the pharmacology.
In plain terms: a slightly steeper slope than semaglutide, but still a slope, not a cliff.
Because the normal interval (7 days) already sits past one half-life, tirzepatide's weekly trough is naturally lower than semaglutide's — and a missed dose extends that decline further along the curve. Steady-state accumulation adds a buffer on top.
The point
The shape of the dip is set by the half-life. A shorter half-life means a steeper decline between doses and after a miss — the same reason tirzepatide's curve looks slightly "tighter" than semaglutide's. This is kinetics, not dosing guidance.
Modelling the dip from your own logged doses turns "did I miss one?" into a visible curve. Zyra Labs shows it — as information only, not medical advice.
Frequently asked
How much tirzepatide is left a few days after a missed dose?
With a ~5-day half-life, about half of the last dose remains at 5 days and about a quarter at 10 days. So a missed weekly dose leaves levels declining gradually rather than disappearing. What to do about it is a clinical question for the label and a clinician.
Is a missed tirzepatide dose worse than a missed semaglutide dose?
Pharmacologically, tirzepatide's shorter half-life means its curve declines a little faster between doses, so a late dose lands lower. Both are cushioned by a multi-day half-life and by accumulation; neither crashes to zero. What to do about a miss is a clinical question.
Does accumulation help after a missed dose?
Yes. At steady-state there is compound left over from earlier doses, which sits underneath the decaying last dose and softens the trough a missed dose creates.
References
Furihata K, Mimura H, Urva S, et al. A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes.Diabetes Obes Metab. 2022. DOI 10.1111/dom.14572
Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications (4th ed.).Lippincott Williams & Wilkins. 2011. ISBN 978-0-7817-5009-7
Zyra Labs is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.